Swiss Re AG Earnings Call Transcripts
Fiscal Year 2026
-
Record net income and strong capital position enabled a higher dividend and share buyback. Strategic focus on core business, technology, and sustainability was reaffirmed, with all board proposals and compensation motions approved. Shareholders raised climate and governance concerns.
Fiscal Year 2025
-
Record net income of $4.8B and 20% ROE in 2025, with strong P&C and Corporate Solutions performance, robust capital returns, and a focus on resilience. Outlook for 2026 targets $4.5B net income and continued cost reductions.
-
Record net income of $4.8B in 2025 exceeded targets, driven by strong underwriting, cost savings, and portfolio resilience. Shareholder returns rise with a $1.5B buyback and 9% dividend hike, while 2026 guidance reflects normalized catastrophe assumptions.
-
Management emphasizes disciplined growth, resilience, and technical excellence, targeting $4.5B net income and 20% ROE for 2026. Portfolio repositioning, cost reductions, and AI-driven transformation underpin performance, while a new $500M annual buyback complements a >7% dividend growth policy.
-
Net income reached $4B for the first nine months, with strong P&C results and robust capital. Life & Health Re is expected to miss its full-year target due to negative assumption updates, but group guidance remains unchanged.
-
Net income reached $2.6B in H1 2025 with a 23% ROE, driven by strong P&C underwriting and disciplined portfolio management. Combined ratios in P&C and Corporate Solutions outperformed targets, while Life and Health Re delivered solid results amid ongoing portfolio adjustments.
-
Net income reached $2.6 billion for H1 2025, driven by strong underwriting, disciplined portfolio management, and robust investment returns. Combined ratios improved across segments, and the SST ratio rose to 264%, supporting confidence in full-year targets.
-
Q1 net income reached $1.3 billion with a 22% ROE, supported by strong investment returns and resilient segment performance despite large losses. Revenues were stable on an underlying basis, and the group remains confident in meeting 2025 targets amid ongoing volatility.
-
Shareholders approved all agenda items, including a higher dividend and board elections, with strong majorities. Management addressed climate, ESG, and liability risks, outlined strategic withdrawals and growth targets, and reinforced commitments to sustainability and prudent risk management.
Fiscal Year 2024
-
Net income reached $3.2 billion in 2024 with a 15% ROE, driven by strong P&C reserve actions, robust Corporate Solutions performance, and Life & Health Re meeting targets. 2025 guidance remains confident at $4.4 billion net income, despite LA wildfire losses.
-
Management outlined a focused strategy to address reserve drag, enhance technical excellence, and drive cost savings, raising 2025 net income guidance to over $4.4 billion and targeting a 7%+ annual dividend increase. Portfolio shifts, prudent reserving, and technology investments support these ambitions.
-
Significant US liability reserve strengthening led to a $3.1 billion addition YTD, positioning reserves at the 90th percentile and enhancing resilience. Despite this, strong underwriting and investment results drove $2.2 billion net income for nine months, with 2024 net income expected to exceed $3 billion.
-
Net income reached $2.1 billion in H1 2024, with all segments contributing to strong results and the group on track for its $3.6 billion+ full-year target. Prudent reserving, robust capital, and disciplined underwriting underpin resilience as the group enters hurricane season.